The predictive value of prognostic immune and nutritional index in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy: a retrospective propensity score matching study

1

The prognostic immune and nutritional index (PINI) is a significant predictor of clinical outcomes in esophageal squamous cell carcinoma (ESCC) patients.
2

A study of 193 ESCC patients undergoing neoadjuvant immunochemotherapy established a PINI cutoff of 3.320 to differentiate survival outcomes.
3

Patients with low PINI showed significantly worse disease-free survival (DFS) and overall survival (OS) compared to those with high PINI.
4

Multivariate analysis confirmed PINI as an independent prognostic index for DFS and OS in the pre-matched cohort of ESCC patients.
5

Incorporating PINI into existing prognostic models may enhance long-term risk stratification and personalize treatment strategies for ESCC.

1